Suppr超能文献

学术性基层医疗环境中高风险慢性阿片类药物处方的预测因素

Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting.

作者信息

Bauer Scott R, Hitchner Lily, Harrison Hannah, Gerstenberger John, Steiger Scott

机构信息

a Division of General Internal Medicine , University of California San Francisco , San Francisco , California , USA.

b School of Medicine , University of California, San Francisco , San Francisco , California , USA.

出版信息

Subst Abus. 2016;37(1):110-7. doi: 10.1080/08897077.2015.1129020.

Abstract

BACKGROUND

Patients with chronic noncancer pain treated with higher doses of opioids or concurrent substance use are at increased risk of adverse events. Although several national guidelines recommend maximum dosing thresholds and urine drug testing, adherence to these guidelines is inconsistent.

METHODS

To identify predictors of higher-risk opioid prescriptions in 2 academic primary care clinics, the authors developed a retrospective cohort of 842 patients who were prescribed ≥5 opioid prescriptions for noncancer pain between March 2012 and March 2013. The authors evaluated odds of higher-dose opioid prescriptions and urine drug testing using multivariate logistic models.

RESULTS

Among study subjects, 47% received prescriptions for the equivalent of ≥50 mg morphine per day. After adjustment for confounders, patients with a resident primary care provider were less likely to receive higher-dose prescriptions compared with faculty providers (odds ratio = 0.66, 95% confidence interval [CI]: 0.46-0.94), whereas patients with a nonlocal home address were more likely to be prescribed higher doses (odds ratio = 2.1, 95% CI: 1.5-2.9). Hispanic, Asian, and older patients were also less likely to be prescribed higher doses. Urine drug testing was not regularly completed (35% over 2 years), but odds of testing were higher for patients who self-identified as black, had resident primary care providers, lived locally, or were prescribed higher opioid doses.

CONCLUSIONS

In this academic clinical setting, patients with a resident primary care provider are less likely to receive higher-risk opioid prescriptions, as are Hispanic, Asian, and older patients. Black patients complete urine drug tests more frequently independent of other patient and provider characteristics. Additional studies are needed to assess why patients who travel larger distances to their primary care clinic are prescribed higher doses of opioids for chronic noncancer pain.

摘要

背景

接受高剂量阿片类药物治疗或同时使用药物的慢性非癌性疼痛患者发生不良事件的风险增加。尽管多项国家指南推荐了最大剂量阈值和尿液药物检测,但对这些指南的遵守情况并不一致。

方法

为了确定两家学术性初级保健诊所中高风险阿片类药物处方的预测因素,作者建立了一个回顾性队列,纳入了2012年3月至2013年3月期间因非癌性疼痛开具≥5张阿片类药物处方的842例患者。作者使用多变量逻辑模型评估高剂量阿片类药物处方和尿液药物检测的几率。

结果

在研究对象中,47%的患者接受了相当于每天≥50毫克吗啡的处方。在对混杂因素进行调整后,与教员提供者相比,有住院初级保健提供者的患者接受高剂量处方的可能性较小(优势比=0.66,95%置信区间[CI]:0.46-0.94),而家庭住址不在当地的患者更有可能被开具高剂量处方(优势比=2.1,95%CI:1.5-2.9)。西班牙裔、亚裔和老年患者被开具高剂量处方的可能性也较小。尿液药物检测未定期完成(两年内为35%),但自我认定为黑人、有住院初级保健提供者、居住在当地或被开具较高阿片类药物剂量的患者检测几率较高。

结论

在这种学术临床环境中,有住院初级保健提供者的患者、西班牙裔、亚裔和老年患者接受高风险阿片类药物处方的可能性较小。黑人患者更频繁地完成尿液药物检测,与其他患者和提供者特征无关。需要进一步研究来评估为什么前往初级保健诊所路途较远的患者因慢性非癌性疼痛被开具较高剂量的阿片类药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验